ClinicalTrials.gg
CompletedNCT07825922Updated Sep 17, 2026

Analgesic Efficacy of Peritonsillar Ropivacaine Infiltration After Tonsillectomy in Children

An interventional study of Peritonsillar infiltration with ropivacaine and Peritonsillar infiltration with normal saline in Tonsillectomy, Ropivacaine and Analgesia, sponsored by University Hospital, Mahdia. Completed at 1 site in Tunisia. Open to participants aged 3 Years to 6 Years. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by University Hospital, Mahdia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 6 months after the study started (first participant enrolled Mar 2024, registered Sep 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
3 Years to 6 Years
Sex
All
01

Study summary

Tonsillectomy is one of the most frequently performed surgical procedures in children and is commonly associated with significant postoperative pain. Peritonsillar infiltration with local anesthetics such as Ropivacaine has been proposed to improve analgesia, but evidence remains inconsistent. This study aimed to evaluate the analgesic efficacy of peritonsillar Ropivacaine infiltration in pediatric tonsillectomy.

02

Conditions studied

  • Tonsillectomy
  • Ropivacaine
  • Analgesia
  • Local Anesthesia
  • Children
03

In context

Lead sponsor

University Hospital, Mahdia is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 3-6 years
  • classified as
  • scheduled for elective tonsillectomy without adenoidectomy

Exclusion criteria

Exclusion Criteria:

  • systemic diseases (hepatic, renal, hematologic, or cardiac)
  • obesity ( ≥ 95th percentile)
  • upper respiratory infection within two weeks
  • chronic analgesic use
  • known allergy to local anesthetics
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Placebo comparator
    Group 1 (Placebo)

    patients will receive peritonsillar infiltration with normal saline

    Other: Peritonsillar infiltration with normal saline · Drug: Normal Saline

  • Active comparator
    Group 2 (Ropivacaine)

    patients will receive peritonsillar infiltration with ropivacaine

    Other: Peritonsillar infiltration with ropivacaine · Drug: ropivacaine (local infiltration)

Interventions

  • OtherPeritonsillar infiltration with ropivacaine

    Under general anesthesia and before surgical incision, the patient was positioned in Rose's position. Infiltration with ropivacaine was performed after intubation and before incision at three points (superior, middle, and inferior poles, including the posterior pillar), using a 23 gauge needle inserted between the pharyngeal muscles and tonsillar capsule.

  • OtherPeritonsillar infiltration with normal saline

    Under general anesthesia and before surgical incision, the patient was positioned in Rose's position. Infiltration with normal saline was performed after intubation and before incision at three points (superior, middle, and inferior poles, including the posterior pillar), using a 23 gauge needle inserted between the pharyngeal muscles and tonsillar capsule.

  • DrugNormal Saline

    Normal saline 0.9%, 5 mL, administered (2.5 mL per tonsillar bed)

  • Ropivacaine 0.2%, 5 mL, administered (2.5 mL per tonsillar bed)

06

What researchers measure

Primary outcomes

  1. Time to first postoperative analgesic request

    Time from the end of surgery to the first administration of rescue analgesic medication. The time was recorded in hours.

    Time frame: From the end of surgery until 24 hours postoperatively

Secondary outcomes

  1. Intraoperative remifentanil dose (µg)

    It refers to the total dose of remifentanil administered to the patient during the entire surgical procedure. It reflects the amount of opioid used for intraoperative analgesia.

    Time frame: Perioperative.

  2. Paracetamol Consumption at 24h

    It refers to the total dose of paracetamol consumed in the first 24 hours postoperatively, normalized per kilogram of body weight (mg/kg).

    Time frame: In the first 24 hours postoperatively

  3. Time to first oral intake

    Time from the end of surgery to the first oral intake, expressed in hours.

    Time frame: From the end of surgery until first oral intake, assessed during the first 24 hours after surgery.

  4. Face, Legs, Activity, Cry, Consolability scores over 24h

    Postoperative pain intensity assessed using the Face, Legs, Activity, Cry, Consolability scale (FLACC), ranging from 0 (no pain) to 10 (worst possible pain).

    Time frame: At 0, 2, 4, 8, 12 and 24 hours after surgery

  5. Parental satisfaction

    Parents' satisfaction was assessed using a 5-point Likert scale, where 1 indicated very dissatisfied, 5 very satisfied.

    Time frame: At 24 hours after surgery

  6. Incidence of adverse effects

    Occurrence of adverse effects (hypotension, bradycardia, arrhythmia, or local anesthetic toxicity) during or after surgery.

    Time frame: Perioperative.

  7. Need for rescue tramadol

    Once the FLACC score will be ≥ 4, rescue analgesia in the form of tramadol will be given.

    Time frame: Perioperative.

  8. Surgical conditions

    It refers to the surgical dissection evaluated by the surgeon, easy, moderately easy or hard.

    Time frame: Perioperative.

  9. Intraoperative systolic blood pressure

    It refers to the the systolic blood pressure collected intraoperatively every ten minutes.

    Time frame: Perioperative.

  10. Intraoperative diastolic blood pressure.

    It refers to the diastolic blood pressure collected intraoperatively every ten minutes.

    Time frame: Perioperative.

  11. Intraoperative heart rate

    It refers to the heart rate collected intraoperatively every ten minutes.

    Time frame: Perioperative.

07

Study locations

1 site
  • Hôpital Taher Sfar
    Mahdia, Tunisia
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07825922
Lead sponsor
University Hospital, Mahdia
Responsible party
Hela Attia (Principal Investigator, University Hospital, Mahdia) — Principal investigator
First posted
Sep 17, 2026
Start date
Mar 1, 2024
Primary completion
Sep 30, 2024
Completion
Sep 30, 2024
Last update
Sep 17, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Ropivacaine

Start the discussion